PWM
PRME icon

Palumbo Wealth Management’s Prime Medicine PRME Stock Holding History

Palumbo Wealth Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$356K Buy
102,246
+16,707
+20% +$63.6K 0.09% 155
2025
Q4 		$297K Sell
85,539
-6,996
-8% -$31.1K 0.07% 173
2025
Q3 		$513K Sell
92,535
-90,823
-50% -$369K 0.16% 89
2025
Q2 		$453K Buy
183,358
+87,896
+92% +$135K 0.14% 113
2025
Q1 		$190K Buy
+95,462
New +$244K 0.06% 167

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Palumbo Wealth Management's PRME Position: Q1 2026 in Review

Palumbo Wealth Management increased its Prime Medicine (PRME) stake by 20% in Q1 2026, buying an estimated $63.6K and bringing the position to 102,246 shares worth $356K. The position accounts for 0.09% of the portfolio, ranked #155.

Palumbo Wealth Management first reported a position in PRME in Q1 2025 and has held it in 5 quarters since. The position peaked at $513K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Palumbo Wealth Management held 102,246 shares of Prime Medicine worth $356K as of Q1 2026.
  • Palumbo Wealth Management bought 16,707 Prime Medicine shares in Q1 2026, an estimated $63.6K.
  • Prime Medicine made up 0.09% of Palumbo Wealth Management's portfolio in Q1 2026, its #155 holding.
  • Palumbo Wealth Management first reported a position in Prime Medicine in Q1 2025 and has held it in 5 quarters since.
  • Palumbo Wealth Management's Prime Medicine position peaked at $513K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.